Research graph
References from Breaking the AF–TR Cycle: Does Ablation Add Benefits Beyond Antiarrhythmic Therapy?. Local targets link to admitted publications; unresolved targets remain external evidence.
Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation with Concomitant Tricuspid Regurgitation
2000 · External reference
Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment
10.1093/eurheartj/ehae088 · 2024 · External reference
Incidence and Burden of Tricuspid Regurgitation in Patients With Atrial Fibrillation
10.1016/j.jacc.2022.09.045 · 2022 · External reference
Improvement in tricuspid regurgitation following catheter ablation of atrial fibrillation
10.1111/jce.14707 · 2020 · External reference
Long-term outcome of catheter ablation in patients with persistent atrial fibrillation and functional tricuspid regurgitation
10.3389/fcvm.2025.1600238 · 2025 · External reference
Effectiveness of Rhythm Control of Atrial Fibrillation in Moderate-to-Severe or Severe Secondary Tricuspid Regurgitation
10.1016/j.jcmg.2026.03.006 · 2026 · External reference
Improvement of functional mitral and tricuspid regurgitation in patients with atrial fibrillation after sinus rhythm restoration-the Berlin FMTR registry
2026 · External reference
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
10.1093/eurheartj/ehae176 · 2024 · External reference
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
10.1056/nejmoa2019422 · 2020 · External reference
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial
10.1001/jama.2019.0693 · 2019 · External reference
